$106.50
At close: Apr 15 EDT
$106.30
-0.20-0.19%
Pre-Market: 7:17 AM EDT
Comments
Loading...
Gilead Sciences Analyst Ratings and Price Targets | NASDAQ:GILD | Benzinga
Gilead Sciences Inc has a consensus price target of $104.92 based on the ratings of 28 analysts. The high is $140 issued by Wells Fargo on March 5, 2025. The low is $69 issued by HSBC on April 24, 2024. The 3 most-recent analyst ratings were released by JP Morgan, Morgan Stanley, and B of A Securities on March 27, 2025, March 11, 2025, and March 5, 2025, respectively. With an average price target of $128.67 between JP Morgan, Morgan Stanley, and B of A Securities, there's an implied 21.04% upside for Gilead Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Morgan Stanley
B of A Securities
Wells Fargo
Oppenheimer
1calculated from analyst ratings
Analyst Ratings for Gilead Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/27/2025 | Buy Now | 22.3% | JP Morgan | Chris Schott59% | $120 → $130 | Maintains | Overweight | Get Alert |
| 03/11/2025 | Buy Now | 22.3% | Morgan Stanley | Matthew Harrison62% | $123 → $130 | Maintains | Overweight | Get Alert |
| 03/05/2025 | Buy Now | 18.53% | B of A Securities | Tim Anderson53% | $116 → $126 | Maintains | Buy | Get Alert |
| 03/05/2025 | Buy Now | 31.7% | Wells Fargo | Mohit Bansal69% | $120 → $140 | Maintains | Overweight | Get Alert |
| 03/04/2025 | Buy Now | 24.18% | Oppenheimer | Hartaj Singh46% | $115 → $132 | Maintains | Outperform | Get Alert |
| 02/18/2025 | Buy Now | 12.89% | Deutsche Bank | James Shin32% | $80 → $120 | Upgrade | Hold → Buy | Get Alert |
| 02/12/2025 | Buy Now | -15.33% | RBC Capital | Brian Abrahams50% | $84 → $90 | Maintains | Sector Perform | Get Alert |
| 02/12/2025 | Buy Now | -9.69% | Goldman Sachs | Salveen Richter52% | $85 → $96 | Maintains | Neutral | Get Alert |
| 02/12/2025 | Buy Now | 8.18% | BMO Capital | Evan Seigerman64% | $110 → $115 | Maintains | Outperform | Get Alert |
| 02/12/2025 | Buy Now | 12.89% | Wells Fargo | Mohit Bansal69% | $105 → $120 | Maintains | Overweight | Get Alert |
| 02/12/2025 | Buy Now | 3.48% | Piper Sandler | Joseph Catanzaro40% | $105 → $110 | Maintains | Overweight | Get Alert |
| 02/12/2025 | Buy Now | 15.71% | Morgan Stanley | Matthew Harrison62% | $113 → $123 | Maintains | Overweight | Get Alert |
| 02/12/2025 | Buy Now | — | Needham | Joseph Stringer47% | — | Reiterates | Hold → Hold | Get Alert |
| 02/03/2025 | Buy Now | -20.98% | RBC Capital | Brian Abrahams50% | $84 → $84 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 01/29/2025 | Buy Now | 8.18% | JP Morgan | Chris Schott59% | $105 → $115 | Maintains | Overweight | Get Alert |
| 01/10/2025 | Buy Now | 6.3% | Morgan Stanley | Matthew Harrison62% | $87 → $113 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/11/2024 | Buy Now | -24.74% | Cantor Fitzgerald | Olivia Brayer57% | $80 → $80 | Reiterates | Neutral → Neutral | Get Alert |
| 12/11/2024 | Buy Now | -20.98% | RBC Capital | Brian Abrahams50% | $84 → $84 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 12/10/2024 | Buy Now | 8.18% | Oppenheimer | Matthew Biegler36% | $105 → $115 | Reiterates | Outperform → Outperform | Get Alert |
| 12/10/2024 | Buy Now | 2.54% | B of A Securities | Tim Anderson53% | → $109 | Reinstates | → Buy | Get Alert |
| 11/21/2024 | Buy Now | -9.69% | UBS | Colin Bristow39% | $70 → $96 | Maintains | Neutral | Get Alert |
| 11/21/2024 | Buy Now | -5.93% | Mizuho | Salim Syed42% | $90 → $100 | Maintains | Outperform | Get Alert |
| 11/18/2024 | Buy Now | -20.98% | RBC Capital | Brian Abrahams50% | $81 → $84 | Maintains | Sector Perform | Get Alert |
| 11/15/2024 | Buy Now | 3.48% | Wolfe Research | Alexandria Hammond37% | → $110 | Initiates | → Outperform | Get Alert |
| 11/14/2024 | Buy Now | 17.59% | Citigroup | Geoff Meacham60% | → $125 | Initiates | → Buy | Get Alert |
| 11/08/2024 | Buy Now | — | Maxim Group | Jason McCarthy41% | — | Downgrade | Buy → Hold | Get Alert |
| 11/08/2024 | Buy Now | -8.75% | Truist Securities | Asthika Goonewardene40% | $83 → $97 | Maintains | Hold | Get Alert |
| 11/07/2024 | Buy Now | -1.22% | Oppenheimer | Hartaj Singh46% | $95 → $105 | Maintains | Outperform | Get Alert |
| 11/07/2024 | Buy Now | -4.05% | BMO Capital | Evan Seigerman64% | $94 → $102 | Maintains | Outperform | Get Alert |
| 11/07/2024 | Buy Now | -10.63% | Baird | Brian Skorney56% | $80 → $95 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | -1.22% | JP Morgan | Chris Schott59% | $100 → $105 | Maintains | Overweight | Get Alert |
| 11/07/2024 | Buy Now | -23.8% | RBC Capital | Brian Abrahams50% | $75 → $81 | Maintains | Sector Perform | Get Alert |
| 11/07/2024 | Buy Now | -20.98% | Goldman Sachs | Salveen Richter52% | $74 → $84 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | -24.74% | Cantor Fitzgerald | Olivia Brayer57% | $70 → $80 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | -1.22% | Wells Fargo | Mohit Bansal69% | $100 → $105 | Maintains | Overweight | Get Alert |
| 11/07/2024 | Buy Now | -10.63% | Barclays | Carter Gould56% | $84 → $95 | Maintains | Equal-Weight | Get Alert |
| 11/07/2024 | Buy Now | -1.22% | Piper Sandler | Joseph Catanzaro40% | $95 → $105 | Maintains | Overweight | Get Alert |
| 11/07/2024 | Buy Now | — | Needham | Joseph Stringer47% | — | Reiterates | → Hold | Get Alert |
| 10/29/2024 | Buy Now | -29.44% | RBC Capital | Brian Abrahams50% | $75 → $75 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 10/21/2024 | Buy Now | -9.69% | Leerink Partners | Andrew Berens49% | $74 → $96 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/17/2024 | Buy Now | -11.57% | BMO Capital | Evan Seigerman64% | $85 → $94 | Maintains | Outperform | Get Alert |
| 10/17/2024 | Buy Now | -1.22% | Bernstein | Aaron Gal55% | → $105 | Initiates | → Outperform | Get Alert |
| 10/09/2024 | Buy Now | -5.93% | JP Morgan | Chris Schott59% | $95 → $100 | Maintains | Overweight | Get Alert |
| 10/07/2024 | Buy Now | -20.98% | Barclays | Carter Gould56% | $76 → $84 | Maintains | Equal-Weight | Get Alert |
| 10/07/2024 | Buy Now | -5.93% | Wells Fargo | Mohit Bansal69% | $78 → $100 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/04/2024 | Buy Now | -29.44% | RBC Capital | Brian Abrahams50% | $74 → $75 | Maintains | Sector Perform | Get Alert |
| 09/16/2024 | Buy Now | -34.15% | Cantor Fitzgerald | Olivia Brayer57% | $70 → $70 | Reiterates | Neutral → Neutral | Get Alert |
| 09/11/2024 | Buy Now | -10.63% | Piper Sandler | Joseph Catanzaro40% | $95 → $95 | Maintains | Overweight | Get Alert |
| 09/09/2024 | Buy Now | -34.15% | Cantor Fitzgerald | Olivia Brayer57% | $70 → $70 | Reiterates | Neutral → Neutral | Get Alert |
| 09/04/2024 | Buy Now | -30.39% | RBC Capital | Brian Abrahams50% | $72 → $74 | Maintains | Sector Perform | Get Alert |
| 08/15/2024 | Buy Now | -21.92% | Truist Securities | Robyn Karnauskas55% | $82 → $83 | Maintains | Hold | Get Alert |
| 08/15/2024 | Buy Now | — | Needham | Joseph Stringer47% | — | Reiterates | → Hold | Get Alert |
| 08/09/2024 | Buy Now | -32.27% | RBC Capital | Brian Abrahams50% | $71 → $72 | Maintains | Sector Perform | Get Alert |
| 08/09/2024 | Buy Now | -34.15% | Cantor Fitzgerald | Olivia Brayer57% | $70 → $70 | Reiterates | Neutral → Neutral | Get Alert |
| 08/09/2024 | Buy Now | -20.04% | BMO Capital | Evan Seigerman64% | $80 → $85 | Maintains | Outperform | Get Alert |
| 07/22/2024 | Buy Now | -34.15% | Cantor Fitzgerald | Olivia Brayer57% | $75 → $70 | Maintains | Neutral | Get Alert |
| 07/08/2024 | Buy Now | -12.51% | Raymond James | Steven Seedhouse58% | → $93 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/01/2024 | Buy Now | -30.39% | RBC Capital | Brian Abrahams50% | $74 → $74 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 06/20/2024 | Buy Now | -24.74% | Baird | Brian Skorney56% | $80 → $80 | Maintains | Neutral | Get Alert |
| 06/14/2024 | Buy Now | -30.39% | RBC Capital | Brian Abrahams50% | $74 → $74 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 04/29/2024 | Buy Now | -28.5% | Barclays | Carter Gould56% | $80 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | -20.04% | TD Cowen | Tyler Van Buren45% | $90 → $85 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | -26.62% | Morgan Stanley | Matthew Harrison62% | $80 → $78 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | -30.39% | RBC Capital | Brian Abrahams50% | $76 → $74 | Maintains | Sector Perform | Get Alert |
| 04/26/2024 | Buy Now | — | Needham | Joseph Stringer47% | — | Reiterates | → Hold | Get Alert |
| 04/24/2024 | Buy Now | -35.09% | HSBC | Morten Herholdt37% | → $69 | Upgrade | Reduce → Hold | Get Alert |
| 04/19/2024 | Buy Now | -1.22% | Oppenheimer | Hartaj Singh46% | $105 → $105 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | -29.44% | UBS | Colin Bristow39% | $81 → $75 | Maintains | Neutral | Get Alert |
| 03/04/2024 | Buy Now | -26.62% | Wells Fargo | Mohit Bansal69% | $84 → $78 | Maintains | Equal-Weight | Get Alert |
| 02/22/2024 | Buy Now | -15.33% | Mizuho | Salim Syed42% | $101 → $90 | Maintains | Buy | Get Alert |
| 02/22/2024 | Buy Now | -22.86% | Truist Securities | Robyn Karnauskas55% | $91 → $82 | Downgrade | Buy → Hold | Get Alert |
| 02/14/2024 | Buy Now | -29.44% | RBC Capital | Brian Abrahams50% | $76 → $75 | Maintains | Sector Perform | Get Alert |
| 02/12/2024 | Buy Now | -24.74% | Barclays | Carter Gould56% | $85 → $80 | Maintains | Equal-Weight | Get Alert |
| 02/12/2024 | Buy Now | -1.22% | Oppenheimer | Hartaj Singh46% | $115 → $105 | Maintains | Outperform | Get Alert |
| 02/07/2024 | Buy Now | -26.62% | Cantor Fitzgerald | Olivia Brayer57% | $80 → $78 | Maintains | Neutral | Get Alert |
| 02/07/2024 | Buy Now | -28.5% | RBC Capital | Brian Abrahams50% | $78 → $76 | Maintains | Sector Perform | Get Alert |
| 02/07/2024 | Buy Now | -20.98% | Wells Fargo | Mohit Bansal69% | $90 → $84 | Maintains | Equal-Weight | Get Alert |
| 01/23/2024 | Buy Now | -20.04% | Barclays | Carter Gould56% | $82 → $85 | Maintains | Equal-Weight | Get Alert |
| 11/14/2023 | Buy Now | -27.56% | RBC Capital | Brian Abrahams50% | $78 → $77 | Maintains | Sector Perform | Get Alert |
| 11/09/2023 | Buy Now | -29.44% | Deutsche Bank | James Shin32% | → $75 | Initiates | → Hold | Get Alert |
| 09/08/2023 | Buy Now | -10.63% | B of A Securities | Geoff Meacham60% | $88 → $95 | Upgrade | Neutral → Buy | Get Alert |
| 09/06/2023 | Buy Now | -14.39% | Truist Securities | Robyn Karnauskas55% | → $91 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | Buy Now | -33.21% | HSBC | Morten Herholdt37% | → $71 | Initiates | → Reduce | Get Alert |
| 08/04/2023 | Buy Now | -17.22% | Morgan Stanley | Matthew Harrison62% | $86 → $88 | Maintains | Equal-Weight | Get Alert |
| 08/04/2023 | Buy Now | -20.98% | RBC Capital | Brian Abrahams50% | $83 → $84 | Maintains | Sector Perform | Get Alert |
| 07/24/2023 | Buy Now | -5.93% | Piper Sandler | Joseph Catanzaro40% | $105 → $100 | Maintains | Overweight | Get Alert |
| 07/24/2023 | Buy Now | -24.74% | Cantor Fitzgerald | Olivia Brayer57% | → $80 | Reiterates | Neutral → Neutral | Get Alert |
| 07/24/2023 | Buy Now | -24.74% | Barclays | Carter Gould56% | $81 → $80 | Maintains | Equal-Weight | Get Alert |
| 07/20/2023 | Buy Now | -24.74% | Cantor Fitzgerald | Olivia Brayer57% | $85 → $80 | Maintains | Neutral | Get Alert |
| 07/11/2023 | Buy Now | -19.1% | Morgan Stanley | Matthew Harrison62% | $86 → $86 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/11/2023 | Buy Now | -23.8% | Barclays | Carter Gould56% | $84 → $81 | Maintains | Equal-Weight | Get Alert |
| 06/23/2023 | Buy Now | -17.22% | RBC Capital | Brian Abrahams50% | $88 → $88 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 05/16/2023 | Buy Now | -5.93% | BMO Capital | Evan Seigerman64% | $90 → $100 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/01/2023 | Buy Now | -19.1% | Morgan Stanley | Matthew Harrison62% | $85 → $86 | Maintains | Equal-Weight | Get Alert |
| 04/28/2023 | Buy Now | -17.22% | RBC Capital | Brian Abrahams50% | $87 → $88 | Maintains | Sector Perform | Get Alert |
| 04/28/2023 | Buy Now | -1.22% | Piper Sandler | Joseph Catanzaro40% | → $105 | Assumes | → Overweight | Get Alert |
| 04/25/2023 | Buy Now | -18.16% | RBC Capital | Brian Abrahams50% | → $87 | Reiterates | → Sector Perform | Get Alert |
| 04/12/2023 | Buy Now | -20.04% | Morgan Stanley | Matthew Harrison62% | $81 → $85 | Maintains | Equal-Weight | Get Alert |
| 03/06/2023 | Buy Now | -19.1% | RBC Capital | Brian Abrahams50% | $87 → $86 | Maintains | Sector Perform | Get Alert |
| 02/14/2023 | Buy Now | -4.99% | Mizuho | Salim Syed42% | $88 → $101 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Gilead Sciences (GILD) stock?
The latest price target for Gilead Sciences (NASDAQ:GILD) was reported by JP Morgan on March 27, 2025. The analyst firm set a price target for $130.00 expecting GILD to rise to within 12 months (a possible 22.30% upside). 68 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Gilead Sciences (GILD)?
The latest analyst rating for Gilead Sciences (NASDAQ:GILD) was provided by JP Morgan, and Gilead Sciences maintained their overweight rating.
When was the last upgrade for Gilead Sciences (GILD)?
The last upgrade for Gilead Sciences Inc happened on February 18, 2025 when Deutsche Bank raised their price target to $120. Deutsche Bank previously had a hold for Gilead Sciences Inc.
When was the last downgrade for Gilead Sciences (GILD)?
The last downgrade for Gilead Sciences Inc happened on November 8, 2024 when Maxim Group changed their price target from N/A to N/A for Gilead Sciences Inc.
When is the next analyst rating going to be posted or updated for Gilead Sciences (GILD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gilead Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gilead Sciences was filed on March 27, 2025 so you should expect the next rating to be made available sometime around March 27, 2026.
Is the Analyst Rating Gilead Sciences (GILD) correct?
While ratings are subjective and will change, the latest Gilead Sciences (GILD) rating was a maintained with a price target of $120.00 to $130.00. The current price Gilead Sciences (GILD) is trading at is $106.30, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.